Catalyst Funds Management Pty Ltd

Source: SEC Form 13F · as of Mar 2026

Catalyst Funds Management Pty Ltd holds 81 biotech & pharma companies tracked by BioSniper, totaling $56.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

81

Total value held

$56.3M

CompanySharesValue
AZNASTRAZENECA PLC58,884$9.1M
ABBVAbbVie Inc.34,808$7.6M
RVMDREVOLUTION MEDICINES, INC.66,261$6.4M
RPRXRoyalty Pharma plc79,147$3.8M
MRNAModerna, Inc.55,363$2.8M
BMYBRISTOL MYERS SQUIBB CO42,082$2.6M
BIIBBIOGEN INC.11,970$2.2M
LLYELI LILLY & Co2,004$1.8M
GMOptec International, Inc.20,898$1.6M
JNJJOHNSON & JOHNSON5,739$1.4M
MCKMcKesson Corporation1,179$1.0M
BAXBaxter International Inc.54,300$912K
AMGNAMGEN INC2,453$863K
PMPhilip Morris International Inc4,922$814K
PTCTPTC THERAPEUTICS, INC.11,200$763K
ROIVRoivant Sciences Ltd.25,031$693K
KNSAKiniksa Pharmaceuticals International, plc13,400$645K
ABVXAbivax SA5,000$557K
CAHCardinal Health Inc.2,501$528K
GILDGILEAD SCIENCES, INC.3,791$528K
ZTSZoetis Inc.4,378$518K
MEDPMedpace Holdings Inc.1,040$499K
NKTRNEKTAR THERAPEUTICS6,700$482K
MOHMolina Healthcare Inc3,547$473K
DMRADamora Therapeutics, Inc.17,293$448K
MRKMerck & Co., Inc.3,616$435K
VRTXVERTEX PHARMACEUTICALS INC / MA965$431K
SRPTSarepta Therapeutics, Inc.19,200$418K
ATAIAtai Beckley N.V.113,400$401K
OCGNOcugen, Inc.180,600$327K
LXRXLEXICON PHARMACEUTICALS, INC.207,900$324K
DVADaVita Inc.2,101$323K
MDGLMADRIGAL PHARMACEUTICALS, INC.613$321K
RIOTRiot Platforms, Inc.23,800$294K
ACHCAcadia Healthcare Company Inc.12,100$283K
LCTXLineage Cell Therapeutics, Inc.170,300$269K
ANROAlto Neuroscience, Inc.11,400$256K
CTMXCytomX Therapeutics, Inc.51,600$243K
RLMDRELMADA THERAPEUTICS, INC.34,057$237K
DGXQuest Diagnostics Incorporated1,065$209K
XFORX4 Pharmaceuticals, Inc47,383$196K
MYGNMYRIAD GENETICS INC33,980$153K
VTRSViatris Inc10,641$144K
OBIOOrchestra BioMed Holdings Inc.27,644$117K
ABOSAcumen Pharmaceuticals, Inc.45,600$108K
WHWKWhitehawk Therapeutics, Inc.27,011$93K
ZURAZura Bio Ltd15,300$91K
PROKPROKIDNEY CORP.47,800$86K
ORMPORAMED PHARMACEUTICALS INC.23,500$80K
IVVDInvivyd, Inc.60,400$79K
SGMTSagimet Biosciences Inc.13,900$73K
MNKDMANNKIND CORP29,035$71K
CCCCC4 Therapeutics, Inc.25,740$68K
TSHATaysha Gene Therapies, Inc.15,100$67K
IMRXImmuneering Corp12,800$67K
MDXHMDxHealth SA28,046$65K
GALTGALECTIN THERAPEUTICS INC22,500$63K
CRBUCaribou Biosciences, Inc.32,200$61K
OGNOrganon & Co.10,000$60K
SABSSAB BIOTHERAPEUTICS, INC.15,100$58K
CABACabaletta Bio, Inc.21,300$57K
PALIPALISADE BIO, INC.31,400$55K
ACHVACHIEVE LIFE SCIENCES, INC.18,000$53K
GNLXGENELUX Corp21,824$53K
MBOTMicrobot Medical Inc.21,900$53K
MGNXMACROGENICS INC17,700$51K
NUVBNuvation Bio Inc.10,600$45K
CGTXCOGNITION THERAPEUTICS INC52,800$40K
ZNTLZentalis Pharmaceuticals, Inc.16,700$39K
BDTXBlack Diamond Therapeutics, Inc.15,200$32K
ANIXAnixa Biosciences Inc12,300$32K
FLNAFilana Therapeutics Inc.18,100$31K
PYXSPyxis Oncology, Inc.20,400$30K
PEPGPepGen Inc.15,300$27K
BMEABiomea Fusion, Inc.16,800$26K
ALTSALT5 Sigma Corp21,800$24K
TNYATenaya Therapeutics, Inc.33,200$23K
GUTSFractyl Health Inc.46,800$21K
MAIAMAIA Biotechnology, Inc.10,800$15K
RANIRani Therapeutics Holdings, Inc.14,800$11K
UPXIUPEXI, INC.10,500$10K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Catalyst Funds Management Pty Ltd — Biotech 13F Holdings & Portfolio | BioSniper